REGINfo: GALAPAGOS - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- MAZOR ROBOTICS
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- POALIM
- SHUFERSAL
- SODASTREAM
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

COMPANY SEARCH RESULT

$GALAPAGOS: Click to view the issuer\'s details$

Last update : 21/08/2018 >View issuer details

2018.10.24 | 22:03 | Permanent Information Releases / Sales and Revenues

puce Hallmark third quarter 2018 and Annual R&D Update at Galapagos - HTML (w)

2018.10.24 | 22:03 | Permanent Information Releases / Sales and Revenues

puce Uitstekend derde kwartaal 2018 & jaarlijkse R&D Update bij Galapagos - HTML (w)

2018.10.24 | 22:02 | Permanent Information Releases / General Company News

puce Galapagos and AbbVie restructure CF collaboration - HTML (w)

2018.10.24 | 22:02 | Permanent Information Releases / General Company News

puce Galapagos en AbbVie herstructureren samenwerking in CF - HTML (w)

2018.10.24 | 22:01 | Permanent Information Releases / General Company News

puce Topline interim results of FALCON trial Part 1 in CF - HTML (w)

2018.10.24 | 22:01 | Permanent Information Releases / General Company News

puce Tussentijdse resultaten van het eerste deel van de FALCON studie in CF - HTML (w)

2018.10.22 | 19:15 | Permanent Information Releases / General Company News

puce POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET - HTML (w)

2018.10.22 | 19:15 | Permanent Information Releases / General Company News

puce POSITIEVE RESULTATEN VOOR FILGOTINIB IN PSORIATISCHE ARTRITIS EN ZIEKTE VAN BECHTEREW GEPUBLICEERD IN THE LANCET - HTML (w)

2018.10.22 | Periodic information / 3rd Quarter Information

puce GALAPAGOS : Q3 Report 2018 - PDF (2Mb)

2018.10.22 | Periodic information / 3rd Quarter Information

puce GALAPAGOS : Derde kwartaalverslag 2018 - PDF (2Mb)

2018.10.21 | 00:30 | Permanent Information Releases / General Company News

puce PHASE 3 DATA ON FILGOTINIB IN BIOLOGIC-EXPERIENCED RHEUMATOID ARTHRITIS TO BE PRESENTED AT 2018 ACR/ARHP ANNUAL MEETING - HTML (w)

2018.10.21 | 00:30 | Permanent Information Releases / General Company News

puce FASE 3 RESULTATEN OVER FILGOTINIB IN REUMA GEPRESENTEERD OP JAARLIJKSE ACR/ARHP CONGRES 2018 - HTML (w)

2018.10.03 | 22:01 | Permanent Information Releases / Operations

puce Galapagos increases share capital through warrant exercises - HTML (w)

2018.10.03 | 22:01 | Permanent Information Releases / Operations

puce Galapagos verhoogt kapitaal door uitoefening van warrants - HTML (w)

2018.09.24 | 07:30 | Permanent Information Releases / General Company News

puce Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 152